Mouse models of laminopathies

scientific article

Mouse models of laminopathies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/ACEL.12021
P3181OpenCitations bibliographic resource ID1273865
P698PubMed publication ID23095062
P5875ResearchGate publication ID232698503

P2093author name stringHaoyue Zhang
Kan Cao
Julia E. Kieckhaefer
P2860cites workThe mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skinQ21144407
Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular agingQ24311723
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndromeQ24531946
Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndromeQ24539118
Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndromeQ24562621
Lamin B1 is required for mouse development and nuclear integrityQ24564213
Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblastsQ24634195
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse modelQ24657266
Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophyQ24681029
Lamin A-dependent nuclear defects in human agingQ24681309
Laminopathies and the long strange trip from basic cell biology to therapyQ28251294
Human laminopathies: nuclei gone genetically awryQ28276671
Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoterQ28589439
Decreased bone formation and osteopenia in lamin a/c-deficient miceQ33890914
The lethal phenotype of a homozygous nonsense mutation in the lamin A/C geneQ63531193
Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophyQ79851107
Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal diseaseQ80853720
Stem cell depletion in Hutchinson-Gilford progeria syndromeQ84916810
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.Q33895774
An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeriaQ33904465
Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in miceQ33966782
Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonatesQ34018880
Nuclear lamins: their structure, assembly, and interactionsQ34067345
Nuclear laminsQ34136884
Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in ProgeriaQ34137401
Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.Q34191451
Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cellsQ34196369
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging.Q34248086
The nuclear lamina comes of age.Q34390408
Prelamin A and lamin A appear to be dispensable in the nuclear laminaQ34416396
Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerinQ34470636
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndromeQ34480435
A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.Q34495371
A mitotic lamin B matrix induced by RanGTP required for spindle assemblyQ34502865
Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatinQ34766646
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.Q34803249
The laminopathies: nuclear structure meets diseaseQ35145852
Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins.Q35146605
A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cellsQ35677842
Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.Q35787261
Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cellsQ35835899
Automated image analysis of nuclear shape: what can we learn from a prematurely aged cell?Q35857196
Mouse models of the laminopathies.Q35942479
Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.Q36731585
Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.Q36852109
Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skinQ37323331
B-type lamins and their elusive roles in metazoan cell proliferation and senescenceQ42223376
Reversible phenotype in a mouse model of Hutchinson-Gilford progeria syndromeQ43870213
Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.Q52046408
A progeroid syndrome in mice is caused by defects in A-type laminsQ52105480
Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.Q52545724
Splicing-Directed Therapy in a New Mouse Model of Human Accelerated AgingQ57082619
Lamin A/C deficiency is associated with fat infiltration of muscle and boneQ57086315
Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathiesQ60535383
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)2-10
P577publication date2013-02-01
P1433published inAging CellQ2221073
P1476titleMouse models of laminopathies
P478volume12

Reverse relations

cites work (P2860)
Q41422120A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells
Q54971907Alternative mRNA Splicing in the Pathogenesis of Obesity.
Q40634162An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells
Q57165494Cardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence
Q37469701Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations
Q34614178Cellular mechanosensing: getting to the nucleus of it all.
Q36580567Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome
Q34480944DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome.
Q89999227Diminished Canonical β-Catenin Signaling During Osteoblast Differentiation Contributes to Osteopenia in Progeria
Q33855932Distinct Fiber Type Signature in Mouse Muscles Expressing a Mutant Lamin A Responsible for Congenital Muscular Dystrophy in a Patient.
Q64074438Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome
Q89965056High Fidelity of Mouse Models Mimicking Human Genetic Skeletal Disorders
Q38578682Hutchinson-Gilford progeria syndrome as a model for vascular aging
Q38087992Implications of multipotent mesenchymal stromal cell aging
Q51731708Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan.
Q39072434Lamin A Δexon9 mutation leads to telomere and chromatin defects but not genomic instability.
Q34547899Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrest
Q54945496Lamins and bone disorders: current understanding and perspectives.
Q33551452Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease
Q36210071Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome
Q35218759Low levels of the reverse transactivator fail to induce target transgene expression in vascular smooth muscle cells
Q34338745Nuclear lamina builds tissues from the stem cell niche
Q33638752Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targeting
Q41457647Phenotype-Dependent Coexpression Gene Clusters: Application to Normal and Premature Ageing
Q51281097Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice.
Q55400232SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells.
Q91141600Single molecule analysis of lamin dynamics
Q36931652Targeting Mitogen-Activated Protein Kinase Signaling in Mouse Models of Cardiomyopathy Caused by Lamin A/C Gene Mutations
Q64051766The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy
Q53080649The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.
Q42434438The decision-making process and criteria in selecting candidate drugs for progeria clinical trials
Q42017705Transgenic mice overexpressing glia maturation factor-β, an oxidative stress inducible gene, show premature aging due to Zmpste24 down-regulation
Q90393795Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment
Q26827624When lamins go bad: nuclear structure and disease

Search more.